跳至主要内容
临床试验/NCT02008266
NCT02008266已完成不适用

Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.

Hoffmann-La Roche0 个研究点目标入组 532 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
532
主要终点
Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression.

研究概览

简要总结

This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rheumatoid arthritis progressing for < 2 years.

排除标准

  • Rheumatoid arthritis progressing for < 3 months.
  • Rheumatoid arthritis onset at < 18 years of age.
  • Participation in another clinical study.
  • Rheumatoid arthritis related connective tissue disorder.
  • Any neuropsychological disorders.

结局指标

主要结局

Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression.

时间窗: Single observational visit [Day 1]

次要结局

  • Measure disease activity using DAS 28 assessment.(Single observational visit [Day 1])
  • Assess joint damage using the modified SHARP method.(Single observational visit [Day 1])
  • Assess functional status of patients using the Health Assessment Questionnaire (HAQ).(Single observational visit [Day 1])

研究者

申办方类型
Industry
责任方
Sponsor

相似试验